Lupin launches Clobetasol Propionate corticosteroid cream in US

Lupin launches Clobetasol Propionate corticosteroid cream in US

2018-08-21T15:53:54+00:00 On

Pharma major Lupin said it has launched corticosteroid cream Clobetasol Propionate in the US. The cream is the generic equivalent of Fougera Pharmaceuticals Inc.’s Temovate. Clobetasol Propionate Cream USP 0.05% had annual sales of approximately USD 108.6 million in the US. It is…

Alembic Pharma gets tentative generic nod for Allergan’s Latisse

Alembic Pharma gets tentative generic nod for Allergan’s Latisse

2018-08-06T11:36:17+00:00 On

Alembic Pharmaceuticals said it received tentative approval from the US Food & Drug Administration for launching a therapeutic equivalent of Latisse ophthalmic solution. Allergan Bimatoprost solution is used to treat loss of hair, or hypotrichosis, of the eyelashes. The solution, with an…

1,104 people die during clinical trials in India in 3 years

1,104 people die during clinical trials in India in 3 years

2018-08-06T08:46:08+00:00 On

A total of 1,104 people have died during clinical trials of various drugs and procedures in India in the last three years, according to the ministry of health and family welfare. However, not everyone who died during clinical trials are found to…

Sun Pharma launches diabetes drug metformin in the US

Sun Pharma launches diabetes drug metformin in the US

2018-07-25T13:19:21+00:00 On

Sun Pharmaceutical Industries  said it has launched the glucose regulating drug  metformin hydrochloride in the United States. The tablets in two strengths — 500 mg and 1000 mg —  have an addressable market size  of around $443 million, the company said, quoting…

Glenmark Pharma gets USFDA approval for generic cholesterol drug

Glenmark Pharma gets USFDA approval for generic cholesterol drug

2018-07-17T09:16:25+00:00 On

Glenmark Pharmaceuticals said received approval from the United States Food & Drug Administration to sell cholesterol-lowering drug Colesevelam Hydrochloride in the country. The approval is for two packet sizes – 1.875 grams and 3.75 grams. Colesevelam Hydrochloride is the generic version of Daiichi…

Lupin’s Goa plant completes successful inspection by UK MHRA

Lupin’s Goa plant completes successful inspection by UK MHRA

2018-07-16T11:31:19+00:00 On

Pharma major Lupin said its Goa facility has successfully completed an inspection by the UK Medicines and Healthcare Products Regulatory Authority. “There were no critical or major observations in the inspection,” it said, indicating that products made at the facility can continue…

Zydus Cadila gets tentative US approval for iron excess drug

Zydus Cadila gets tentative US approval for iron excess drug

2018-07-07T12:30:56+00:00 On

Zydus Cadila said it has received tentative regulatory approval from the US Food & Drug Administration for selling Deferasirox, used to chelate or expel excess iron from the blood. The drug is sold under names such as Exjade, Desirox, Defrijet, Desifer, Rasiroxpine…

Cipla wins approval for generic testosterone in the US

Cipla wins approval for generic testosterone in the US

2018-06-21T09:47:03+00:00 On

Drug maker Cipla said it received final approval for selling a generic testosterone injection in the US. Cipla’s Testosterone Cypionate Injection 100mg /ml and 200mg /ml is an AO-rated generic equivalent version of Pharmacia and Upjohn’s Depo-Testosterone. Depo-Testosterone and its generic equivalents…

Zydus receives US nod for generic Cialis ahead of patent expiry

Zydus receives US nod for generic Cialis ahead of patent expiry

2018-06-19T12:47:50+00:00 On

Zydus Cadila, one of India’s largest drug makers, said it has received tentative approval to market tadalafil, the generic ingredient of the most popular erectile dysfunction drug Cialis, in the US market. The drug will be manufactured at the group’s facility at Moraiya,…

Lupin ties up with Japan-based Nichi-Iko for biosimilar launch

Lupin ties up with Japan-based Nichi-Iko for biosimilar launch

2018-06-18T11:21:47+00:00 On

Indian Pharma major Lupin said it has signed an agreement with Japan-based generics maker Nichi-Iko to market its upcoming biosimilar drug, Etanercept, in the far eastern nation. Etanercept, already approved in the US, is used to treat inflammatory conditions. It is pending…

Alembic Pharma gets nod for doxycylcine antibiotic in the US

Alembic Pharma gets nod for doxycylcine antibiotic in the US

2018-06-14T11:04:29+00:00 On

Alembic Pharmaceuticals said the USFDA has permitted it to sell antibiotic doxycycline in the US market. Doxycycline Hyclate Capsules USP, 50 mg and 100 mg, are considered a medium sized drug from a market perspective and had sales of US$ 80 million…

Cipla to sell Eli Lilly’s Basaglar insulin in India

Cipla to sell Eli Lilly’s Basaglar insulin in India

2018-06-08T13:03:14+00:00 On

Indian pharmaceutical giant Cipla Ltd said it would sell Eli Lilly and Co’s insulin glargine in India. Insulin glargine is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. Unlike regular insulin shots —…

Sun Pharma launches authorized version of Daiichi Sankyo’s cholesterol drug in the US

Sun Pharma launches authorized version of Daiichi Sankyo’s cholesterol drug in the US

2018-05-18T08:00:10+00:00 On

India-based Sun Pharmaceutical Industries said it has launched an authorized generic version for Daiichi Sankyo’s cholesterol drug Welchol in the US market. The drug, whose compound name is colesevelam hydrochloride, had US sales of approximately US$ 520 million for the 12 months…

Suven Life Sciences wins 2 patents in Australia,  1 in Singapore

Suven Life Sciences wins 2 patents in Australia, 1 in Singapore

2018-05-17T10:55:26+00:00 On

Pharma player Suven Life Sciences said it received two patents from Australia and one from Singapore for new drugs that can be used for the treatment of disorders associated with Neurodegenerative diseases. “The granted patents include the class of selective H3 Inverse…

Strides Shasun, Apotex to merge Australian ops to create biggest generics player

Strides Shasun, Apotex to merge Australian ops to create biggest generics player

2018-05-09T12:07:22+00:00 On

Pharma player Strides Shasun said it has agreed in principle to merge its Australian business with the Australian operations of peer Apotex. Both have substantial businesses in Australia; Strides under the Arrow brand and Apotex under its primary brand. The merger will…